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lines, collagen, albumin, and other serum proteins occurs in normal individuals and, to a greater extent, in diabetic subjects (1) (2) (3) (4) (5) (6) (7) (8) . Because diabetic nephropathy might result from the glycation of structural glomerular proteins, some investigators have determined the urinary excretion of glycated protein (GP) in diabetics (911) . 1 However, there isstill a paucityof informationabout the urinary excretionof GP, because the previous proceduresfor determining GP were rather difficult and not very sensitive. We therefore developed a simple, highly sensitive RIA for GP, with which we measured the glucitol-lysine residues of glycated protein reduced in vitro. We used this method to investigate the renal handling of GP in normal subjects and in diabetic patients.
Materials and Methods

Preparative Procedures
GP. Proteins were glycated and reduced by use of techniques similar to those described by Curtis 
Subjects
We studied 15 norma! subjectsand 30 diabeticpatients. The diabetic patients were divided into three groups according to their urinary excretion rates of albumin (Ualb): group A, 14 patients with Ua!b <15 tg/min; group B, nine with Ua!b between 15 and 150 .&g/min; and group C, seven with Ualb >150 tg/min. In all patients in groups A and B, urinary protein was qualitatively negative by the Urn lab sticks (Miles Sankyo). Twenty of the patients were receiving insulin therapy: group A, seven; B, six; and C, seven.
Study protocol. In the morning after an overnight fast, 90-mm urine collections were performed; at the midpoint of this period, sera were obtained. Serum and urine samples were stored at -20 #{176}C until the assay.
Assay Procedure
We determined serum and urinary concentrationsof GP as follows. Mix 100 L of serum or urine with 2 mL at 2300 x g at 4#{176}C for30 mm, then count the radioactivity of the precipitate (we used a well-type scintillation counter from Packard, Meriden, CT).
We measured urinary albumin by the specific RIA described previously (16) . Glycated hemoglobin (HbA,) was measured by HPLC (17) . The mean HbA, value of 200 normal subjects was 5.8 (SE 0.02)% of total hemoglobin. To measure serum fructosamine concentrations, we used a fructosamine kit (Roche, Basel, Switzerland); normal values were 2.9 nimol/L.
StatisticalAnalysis
All values were presented as mean ± SE. The differences between the means of the two groups were analyzed by Student's t-test, and correlation coefficients were calculated by the least-squares method. Figure 1 shows the standard curve in the present study and the cross-reactivities with various materials. The antiserum reacted with all kinds of RG1c-proteins studied,e.g.,RG1c-lysine,RG1c-HSA, and RG!c-LDL, but not at all with NRG!c-HSA, HSA, BSA, LDL, controlHSA, controlBSA, controlLDL, mannitol, sorbito!, or lysine.
Results
Assay Performance
We found a significant (P <0.05) differencefor the values of B/T % (quadruplicate determinations) between 0 and 0.5ng ofRG!c-!ysine/tube. Therefore,the minima! detectablequantity was about 0.5 ng of RGlc.lysine/ tube, or 15 pmol/L for a 0.1-mL sample. The dilution curve of serum sample diluted with assay buffer paralleled the standard curve for RG!c-!ysine. The mean analytical recovery rate was 89.2% and 99.0% for serum and urine, respectively. Intra-assay studies gave CVs of 9.1% and 11% at GP concentrations of 98 and 290 pmol/L, respectively (n = 6). We found interassay CVs of 14% and 12% at GP concentrations of 95 and 230 
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and lysine (#{149} U) are comparedwith the standard curve of AGIc-lysine (#{149} #{149}). Eachpoint is the mean value of duplicatedeterminationsin a single assay pmol/L, respectively (n = 5),forsamples assayed within three months of storage.
The following data were obtained by assaying within (r = 0.88,P <0.01, n 30). (Figure 2 , left pane!). However, no significantdifferencewas found between the mean RG!c-lysine value in normal subjectsand that in group A [7.9(SE 1.1) mol/mol protein] (Figure 2 , left pane!).
Measurement of Serum and Urinary GP
HbA1C was not measured in allpatients,but the mean value in group A was 7.9 (SE 0.6)% (n = 10); in group (n = 6).The mean value in these groups exceeded that of normal subjects, but there was no significant difference in mean HbA1 values among the groups. A significant positive correlation was found between SGP and HbA1 (r = 0.61, P <0.01) and between SGP and fasting blood glucose measurements two weeks earlier (r = 0.64,P <0.01).
Urinary concentrations of GP in normal subjects ranged from 3.4 to 13, averaging 6.1 (SE 0.6)mol/L. They were significantly higher in groups B [12 (SE 2) pmo!fL] and C [44 (SE 10) j.mol/L] than in normal subjects and group A [7.1 (SE 0.6) prnol/L]. The glycation ratios of urinary protein (urinary concentrations of GP per mole of protein, UGP) in normal subjects ranged from 4.6 to 54, averaging 20 (SE 4) mol of RGIc-lysine per mole of protein (Figure 2 , right pane!). The ratios were also scattered widely for the diabetics in groups A and B, but were low normal or low for group C ( Figure  2, right panel) . Therefore, the mean value was significantly (P <0.01) lower in group C The mean urinary/serum GP ratio (UGP/SGP), i.e., the selectivity of urinary excretion of GP, was 4.0 (SE 0.8)in normal subjects, not significantly different from that in groups A [3.0(SE 0.6)]and B [2.2(SE 0.5)]. In group C, however, the selectivity of the urinary excretion was significantly (P <0.01) decreased to 0.5 (SE 0.1).
We saw no significant correlation between the selectivity and age, duration of the disease, or HbA1 concentrations. In addition, the mean UGP/SGP ratio in patients was unaffected by insulin therapy. However, patientswith simple diabeticretinopathy (n = 11; five each in groups A and B, and one in group C) had a significantly (P <0.01) lower ratio (1.5 ± 0.2) than did those without retinopathy (n = 13; nine in group A, four in group B), 3.5 (SE 0.6). Moreover, the selectivity ratio in the patients with proliferative-type diabetic retinopathy (six in group C), 0.50 (SE 0.11), was significantly (P <0.01) lower than that in those with simple diabetic retinopathy.
On the other hand, HbA1 concentrations showed no significant correlationwith the progression ofretinopathy.
DIscussion
In the present study, the antiserum produced with
RG1c-HSA antigen bound well all kinds of RG1c-prot, which suggests that the antiserum recognized mainly glucitol-lysine, because allkinds of RGlc-prot had glucitol-lysine as the glucose adduct, unlike NRG!c-prot. However, RGlc-HSA is believed not to exist in vivo (18) . Therefore, for estimating GP by the RIA, we had to reduce samples by using NaBH4 in advance. In addition, because free glucose in serum or urine might lead to falsely high measurements of GP, we effectively eliminated the interference from free glucose by precipitating the proteins with ethanol.
Many papers have been reported about serum GP measured by RIA (13, 14) , as we!! as by the thiobarbituric acid (TBA) method (7, 19) and the fructosamine method (20) . The maximum value of SGP from nondiabetics was three or seven times as high as the minimal value in their reports (7, 19) . This finding is comparable with our result that the maximum value was about three times as high as the minimum value. But, because of the low sensitivity in these assays, a concentrating process was necessary, especially for the measurement of urinary GP (10, 21) . In the present RIA, the minima! detectable quantity, 0.5ng ofRG!c-lysmneper tube,was low enough for measuring GP not only in serum but also in unconcentrated urine. Because glucitol-lysine is thought to be the major borohydride-reducible adduct in urine (22), the UGP estimated by the present RIA probably reflects nearly all the GP in the urine. In addition, the dilution curve was parallel with the standard curve, reproducibility was reliable for three months of storage of the samples, and there was a good correlation between SGP measured by our RLA and by the fructosamine kit. These data validate the use of the present RIA to measure serum and urinary GP.
The urinary excretion of glycated albumin has been measured by the TBA method (10, 21) or by HPLC (11). These methods are time consuming for multiple samples. Using the RIA in this study, one can assay many samples at one time. Moreover, with the present RIA, which measures all glycated molecules as well as albumin, the metabolism of GP can be investigated more extensively than with methods (11) in which albumin is isolated beforeglycated albumin is measured by HPLC. In diabeticpatientswith normal urinary albumin excretion, renal clearance of nonglycated albumin vs the clearance of glycated albumin was significantly increased, whereas in patients with increasing urinary albumin excretion, the ratio was reduced (11). Kverneland et al. (11) suggested that in normo-albuminuric diabetics, nonenzymatic glycation of structural glomerular proteins occurred, and in increased albuminuric patients (in the early stages of diabetic renal disease), structural changes were thought to result from loss of anionic charges, owing to reduced heparan sulfate content in glomerular basement membranes.
However, urinary GP measured by RIA has not yet been reported so far as we know, and the clinical significance of urinary GP is still unclear. Gragnoli et a!. (9) determined urinary GP by the TBA method and demonstrated that in the stage of normoproteinuria, urinary excretion of GP was increased through an increase of UGP (glycation ratio of urinary protein). In the present study, the urinary concentration of GP was significantly higher in the diabeticsin groups B and C than in normal subjectsand the diabeticsin group A, probably because of the increase in the totalurinary protein excretion.
In our study,as urinary albumin excretionincreased, the UGP/SGP ratio,which reflectedthe selectivity of urinary excretionof GP, tended to decrease to <1. The electrical charge and pore sizeof basement membranes are reportedlythe major factors determining the filtration of proteins through the glomerular wall (23, 24) . The pore size was thought to be large in group C. A progressive decrease in UGP in group C probably resulted from severe renal damage, as judged by the degree ofproteinuria.
Ghiggeri et al. (10) demonstrated that the mean urinary glycatedalbumin/serum glycated albumin ratio was about 8 in normal subjects and tended to decrease to about 1 in diabetic patients whose urinary albumin excretion was increased (as determined by the TBA method). We also previously reported a similar tendency (21) . The reason why the ratio was <1 in the present paper is unclear, but the difference might have resulted from the methods of measurement (specificity of the epitope of the antiserum), the difference between glycated albumin and GP, and the variety of the subjects studied.
In the diabetic patients, we found a significant positive correlation between SGP and HbA1C, but not between the selectivity ratio and HbA1C. HbA1C showed no significant correlation with the progression of retinopathy. On the other hand, the selectivity ratio tended to decrease as diabetic nephropathy developed and as urinary albumin excretion increased. Moreover, there was a significant difference in the mean values of selectivity between groups of patients with various degrees of retinopathy.
Therefore, perhaps the progression of retinopathy cannot be attributedto glycemic control alone, and the values for UGP/SGP (selectivity) are more indicative ofthe progression of retinopathy than is HbA1C.
